And they don’t need any exotic manufacturing methods — if you can produce proteins and antibodies at scale, you can probably make AbCs too. The $20 million round was led by Madrona Ventures ...

"Most therapeutic antibodies target a single viral site and lose effectiveness within a year as new variants appear. AMETA, however, is designed to bind to multiple conserved regions of the virus ...

About clesrovimab (MK-1654) Clesrovimab (MK-1654) is an investigational, extended half-life monoclonal antibody (mAb) developed as a passive immunization for the prevention of RSV. Clesrovimab is ...

Immunotherapy is the use of medicines to help a person’s immune system better recognize and destroy cancer cells. Immunotherapy can be used to treat some people with Hodgkin lymphoma (HL). Classic ...